Announcement

Collapse
No announcement yet.

Research Articles Abstract - 2013 Issues Archive

Collapse
X
Collapse
 
  • Page of 4
  • Filter
  • Time
  • Show
Clear All
new posts
Previous 1 4 template Next
  • #1

    Research Articles Abstract - 2013 Issues Archive

    [Source: AMEDEO, homepage: (LINK).]

    Research Articles Abstracts?January 12 2013 Issue




    This week?s abstracts:
    • Antimicrob Agents Chemother
      • ROBBIE GJ , Zhao L, Mondick J, Losonsky G, et al
        • Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children.
    • Antiviral Res
      • MCLEAN GR , Walton RP, Shetty S, Paktiawal N, et al
        • Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1.
    • Epidemiol Infect
      • FOSTER ED , Cavanaugh JE, Haynes WG, Yang M, et al
    • J Clin Microbiol
      • ANANTHANARAYANAN V , Mueller J, Taxy J, Tesic V, et al
    • J Gen Virol
      • PREDICALA R , Zhou Y
      • KOLESNIKOVA L , Heck S, Matrosovich T, Klenk HD, et al
        • Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells.
    • J Infect Dis
      • FLEMING-DUTRA KE , Taylor T, Link-Gelles R, Garg S, et al
      • OMER SB , Zaman K, Roy E, Arifeen SE, et al
        • Combined Effects of Antenatal Influenza Vaccine and Infant Pneumococcal Conjugate Vaccine: Results from a Randomized, Blinded, Controlled Trial.
      • PATHIRANA RD , Bredholt G, Akselsen PE, Pedersen GK, et al
        • A(H1N1)pdm09 vaccination of healthcare workers: Improved immune responses in low responders following revaccination.
      • CHEMALY RF , Torres HA, Munsell MF, Shah DP, et al
        • An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection.
      • SIMONSEN L , Viboud C
      • FORBES RL , Wark PA, Murphy VE, Gibson PG, et al
        • Pregnant women have attenuated innate interferon responses to 2009 pandemic influenza A virus subtype H1N1.
    • J Virol
      • ANGEL M , Kimble JB, Pena L, Wan H, et al
      • DE BAETS S , Schepens B, Sedeyn K, Schotsaert M, et al
        • Recombinant influenza virus carrying the RSV F85-93 CTL epitope reduces respiratory syncytial virus replication in mice.
      • SCHIJF MA , Kruijsen D, Bastiaans J, Coenjaerts FE, et al
        • Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
    • Pediatrics
      • POEHLING KA , Edwards KM, Griffin MR, Szilagyi PG, et al
    • PLoS Comput Biol
      • RATMANN O , Donker G, Meijer A, Fraser C, et al
        • Phylodynamic inference and model assessment with approximate bayesian computation: influenza as a case study.
    • PLoS One
      • CUI H , Gao H, Cui X, Zhao Y, et al
        • Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (AI) Virus H5 Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored AI Vaccine.
      • LAUNAY O , Krivine A, Charlier C, Truster V, et al
        • Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study.
      • ZHAO J , Eisenberg JE, Spicknall IH, Li S, et al
      • HWANG I , Scott JM, Kakarla T, Duriancik DM, et al
      • PROUD D , Hudy MH, Wiehler S, Zaheer RS, et al
        • Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes.
      • HALLORAN SK , Wexler AS, Ristenpart WD
    • Proc Natl Acad Sci U S A
      • WANG J , Wu Y, Ma C, Fiorin G, et al
        • Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
      • ZHU X , Yu W, McBride R, Li Y, et al
        • Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities.
      • KORFHAGEN TR , Kitzmiller J, Chen G, Sridharan A, et al
        • SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia.
    • Vaccine
      • LOEW-BASELLI A , Pavlova BG, Fritsch S, Poellabauer EM, et al
        • A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory.
    -
    ------
    Tags: abstract, archive, research
  • #2
    Research Articles Abstracts?January 20 2013 Issue

    [Source: AMEDEO, homepage: (LINK).]

    Research Articles Abstracts?January 20 2013 Issue




    This week?s abstracts:
    • Arch Virol
      • SIBOONNAN N , Wiriyarat W, Boonarkart C, Chakritbudsabong W, et al
        • A serine-to-asparagine mutation at position 314 of H5N1 avian influenza virus NP is a temperature-sensitive mutation that interferes with nuclear localization of NP.
    • Epidemiol Infect
      • SHANKS GD , Waller M, Smallman-Raynor M
        • Spatiotemporal patterns of pandemic influenza-related deaths in Allied naval forces during 1918.
    • J Immunol
      • JEGASKANDA S , Job ER, Kramski M, Laurie K, et al
        • Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies.
    • J Infect
      • SHIMONI Z , Glick J, Froom P
        • Clinical utility of the full blood count in identifying patients with pandemic influenza a (H1N1).
    • J Infect Dis
      • ZHANG AJ , To KK, Li C, Lau CC, et al
        • Leptin mediates the pathogenesis of severe influenza A(H1N1)pdm09 associated with cytokine dysregulation is preventable by anti-leptin antibody in diet-induced obese mice.
      • COUCH RB , Atmar RL, Franco LM, Quarles JM, et al
        • Antibody Correlates and Predictors of Immunity to Naturally-occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase.
    • J Virol
      • BARANOVICH T , Wong SS, Armstrong J, Marjuki H, et al
      • LEE S , Stokes KL, Currier MG, Sakamoto K, et al
        • Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.
    • JAMA
    • MMWR Morb Mortal Wkly Rep
      • ?
        • Early estimates of seasonal influenza vaccine effectiveness - United States, january 2013.
    • N Engl J Med
      • HABERG SE , Trogstad L, Gunnes N, Wilcox AJ, et al
    • PLoS One
      • MAO L , Wang J, Degrado WF, Inouye M, et al
      • SKOWRONSKI DM , Moser FS, Janjua NZ, Davoudi B, et al
        • H3N2v and Other Influenza Epidemic Risk Based on Age-Specific Estimates of Sero-Protection and Contact Network Interactions.
      • TOMBARI W , Paul M, Bettaieb J, Larbi I, et al
        • Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia.
      • RODRIGUEZ A , Falcon A, Cuevas MT, Pozo F, et al
        • Characterization In Vitro and In Vivo of a Pandemic H1N1 Influenza Virus from a Fatal Case.
      • WOODS CW , McClain MT, Chen M, Zaas AK, et al
        • A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2.
      • SUZUKI M , Yoshimine H, Harada Y, Tsuchiya N, et al
        • Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan.
      • DU L , Zhao G, Sun S, Zhang X, et al
        • A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection.
      • SI Y , de Boer WF, Gong P
        • Different Environmental Drivers of Highly Pathogenic Avian Influenza H5N1 Outbreaks in Poultry and Wild Birds.
      • WANG Z , Chai W, Burwinkel M, Twardziok S, et al
        • Inhibitory Influence of Enterococcus faecium on the Propagation of Swine Influenza A Virus In Vitro.
      • CHOWELL G , Echevarria-Zuno S, Viboud C, Simonsen L, et al
        • Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
    • Vaccine
      • PHONRAT B , Pitisuttithum P, Cahmnanchanunt S, Puthavathana P, et al
        • Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais.
      • JANG YH , Byun YH, Lee DH, Lee KH, et al
        • Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets.
      • ZIMMERMANN U , Gavazzi G, Richard P, Eymin C, et al
        • Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax((R))) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip((R))) to adu
    -
    -------

    Comment

    • #3
      Research Articles Abstracts?January 26 2013 Issue

      [Source: AMEDEO, homepage: (LINK).]

      Research Articles Abstracts?January 26 2013 Issue




      This week?s abstracts:
      • Antimicrob Agents Chemother
        • YATES PJ , Mehta N, Horton J, Tisdale M, et al
          • Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.
      • Biochem Biophys Res Commun
        • GAO R , Du N, Liu D, Zhou J, et al
          • Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1.
      • BMJ
      • Epidemiol Infect
        • ALONSO WJ , Schuck-Paim C
          • What can the 2009 influenza outbreak teach us about the risk of a severe pandemic? The Madagascar experience.
      • J Clin Microbiol
        • MUNRO SB , Kuypers J, Jerome KR
          • Comparison of a Multiplex Real-Time PCR Assay with a Multiplex Luminex Assay for Influenza Virus Detection.
      • J Gen Virol
        • TERRIER O , Textoris J, Carron C, Marcel V, et al
          • Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a.
        • LEE YN , Lee DH, Park JK, Yuk SS, et al
          • Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2).
      • J Infect Dis
        • BATEMAN AC , Kieke BA, Irving SA, Meece JK, et al
          • Effectiveness of Monovalent A(H1N1)pdm09 and 2010-11 Trivalent Inactivated Influenza Vaccines in Wisconsin During the 2010-11 Season.
      • J Virol
        • REECE JC , Alcantara S, Gooneratne S, Jegaskanda S, et al
          • Trivalent live attenuated Influenza-SIV vaccines: efficacy and evolution of CTL escape in macaques.
      • JAMA
        • TALBOT TR , Talbot HK
          • Influenza Prevention Update: Examining Common Arguments Against Influenza Vaccination.
      • N Engl J Med
      • PLoS One
        • AGOLORY SG , Barbot O, Averhoff F, Weiss D, et al
          • Implementation of non-pharmaceutical interventions by new york city public schools to prevent 2009 influenza a.
        • SAMMON CJ , Snowball J, McGrogan A, de Vries CS, et al
          • Evaluating the Hazard of Foetal Death following H1N1 Influenza Vaccination; A Population Based Cohort Study in the UK GPRD.
        • SPAULDING AB , Radi D, Macleod H, Lynfield R, et al
          • Satisfaction and Public Health Cost of a Statewide Influenza Nurse Triage Line in Response to Pandemic H1N1 Influenza.
      • Proc Natl Acad Sci U S A
        • OLDSTONE MB
          • Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza.
      • Vaccine
      • Virus Res
        • SAID A , Lange E, Beer M, Damiani A, et al
          • Recombinant equine herpes virus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.
      -
      ------

      Comment

      • #4
        Research Articles Abstracts?February 2 2013 Issue

        [Source: AMEDEO, homepage: (LINK).]

        Research Articles Abstracts?February 2 2013 Issue




        This Week?s Abstracts:
        • Antimicrob Agents Chemother
          • PIZZORNO A , Abed Y, Rheaume C, Bouhy X, et al
            • Evaluation of recombinant 2009 pandemic influenza A/H1N1 viruses harbouring zanamivir-resistance mutations in mice and ferrets.
        • Biochem Soc Trans
          • VEIT M , Serebryakova MV, Kordyukova LV
        • BMJ
        • J Immunol
          • JOB ER , Deng YM, Barfod KK, Tate MD, et al
            • Addition of Glycosylation to Influenza A Virus Hemagglutinin Modulates Antibody-Mediated Recognition of H1N1 2009 Pandemic Viruses.
        • J Infect Dis
          • PRETORIUS MA , Madhi SA, Cohen C, Naidoo D, et al
            • Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010.
          • KOUASSI DP , Coulibaly D, Foster L, Kadjo H, et al
            • Vulnerable Groups Within a Vulnerable Population: Awareness of the A(H1N1)pdm09 Pandemic and Willingness to Be Vaccinated Among Pregnant Women in Ivory Coast.
          • ISON MG
        • J Virol
          • BEAULIEU A , Gravel E, Cloutier A, Marois I, et al
            • Matriptase Proteolytically Activates Influenza Virus and Promotes Multicycle Replication in the Human Airway Epithelium.
          • BODEWES R , Kreijtz JH, van Amerongen G, Hillaire ML, et al
            • Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal inoculation.
          • INCE WL , Mbaye A, Bennink JR, Yewdell JW, et al
            • Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 genes to Accelerate Adaptation to a New Host.
          • CHEN L , Li F
          • HUANG SS , Banner D, Degousee N, Leon AJ, et al
            • Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.
          • HAO W , Bernard K, Patel N, Ulbrandt N, et al
        • PLoS One
          • HUIJSKENS EG , Reimerink J, Mulder PG, van Beek J, et al
            • Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination.
          • GU Y , Shimada T, Yasui Y, Tada Y, et al
            • National Surveillance of Influenza-Associated Encephalopathy in Japan over Six Years, before and during the 2009-2010 Influenza Pandemic.
          • CHEN Q , Huang S, Chen J, Zhang S, et al
            • NA Proteins of Influenza A Viruses H1N1/2009, H5N1, and H9N2 Show Differential Effects on Infection Initiation, Virus Release, and Cell-Cell Fusion.
          • STOTO MA
            • The effectiveness of U.S. public health surveillance systems for situational awareness during the 2009 H1N1 pandemic: a retrospective analysis.
        • Proc Natl Acad Sci U S A
          • ?
            • Correction for Lin et al., Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.
        • Vaccine
          • PETERS W , Brandl JR, Lindbloom JD, Martinez CJ, et al
            • Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans.
        -
        -------

        Comment

        • #5
          Research Articles Abstracts?February 8 2013 Issue

          [Source: AMEDEO, homepage: (LINK).]

          Research Articles Abstracts?February 8 2013 Issue




          This week?s abstracts:
          • Arch Virol
            • ZHANG F , Fang F, Chang H, Peng B, et al
              • Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine.
          • BMJ
            • RUBINSTEIN F , Micone P, Bonotti A, Wainer V, et al
              • Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study.
          • J Infect Dis
            • LAU LL , Ip DK, Nishiura H, Fang VJ, et al
            • BISCHOFF WE , Swett K, Leng I, Peters TR, et al
          • Pediatrics
            • ATLADOTTIR HO , Henriksen TB, Schendel DE, Parner ET, et al
              • Autism After Infection, Febrile Episodes, and Antibiotic Use During Pregnancy: An Exploratory Study.
            • SANTOS RP , Chao J, Nepo AG, Butt S, et al
              • The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia.
          • PLoS One
            • BALGI AD , Wang J, Cheng DY, Ma C, et al
              • Inhibitors of the influenza a virus m2 proton channel discovered using a high-throughput yeast growth restoration assay.
            • SASAKI Y , Hagiwara K, Kakisaka M, Yamada K, et al
              • Importin alpha3/Qip1 Is Involved in Multiplication of Mutant Influenza Virus with Alanine Mutation at Amino Acid 9 Independently of Nuclear Transport Function.
            • NISHIURA H , Yen HL, Cowling BJ
              • Sample Size Considerations for One-to-One Animal Transmission Studies of the Influenza A Viruses.
            • WU CL , Lu J, Wang MH, Lv X, et al
              • Cross Sectional Survey of Influenza Antibodies before and during the 2009 Pandemic in Shenzhen, China.
            • KANG M , Zhong H, He J, Rutherford S, et al
            • PULESTON R , Bugg G, Hoschler K, Konje J, et al
              • Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03(A)-Adjuvanted H1N1 2009 Vaccine.
            • CARBONARA S , Bruno G, Ciaula GD, Pantaleo AD, et al
              • Correction: Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units.
            • CARBONARA S , Bruno G, Ciaula GD, Pantaleo AD, et al
              • Correction: Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units.
          • Vaccine
            • RISI G , Frenette L, Langley JM, Li P, et al
              • Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.
            • MAGNUSSON SE , Reimer JM, Karlsson KH, Lilja L, et al
              • Immune enhancing properties of the novel Matrix-M adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
            • GARULLI B , Di Mario G, Sciaraffia E, Accapezzato D, et al
              • Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo.
            • BREWOO JN , Powell TD, Jones JC, Gundlach NA, et al
              • Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
          -
          ------

          Comment

          • #6
            Research Articles Abstracts?February 16 2013 Issue

            [Source: AMEDEO, homepage: (LINK).]

            Research Articles Abstracts?February 16 2013 Issue




            This week?s abstracts:
            • Antimicrob Agents Chemother
              • YAMAYA M , Nishimura H, Hatachi Y, Yasuda H, et al
                • Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.
            • Antiviral Res
              • WANG Y , Landman B, Wu C, Gelb J, et al
                • Comparison of vRNA and cRNA based reporters for detection of influenza replication.
            • Arch Virol
              • FALCONE V , Bierbaum S, Kern W, Kontny U, et al
                • Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season.
              • LONG JP , Kotur MS, Stark GV, Warren RL, et al
                • Accumulation of CD11b(+)Gr-1 (+) cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses.
            • BMJ
              • ?
            • Epidemiol Infect
              • CLAES G , Welby S, VAN DEN Berg T, VAN DER Stede Y, et al
                • The impact of viral tropism and housing conditions on the transmission of three H5/H7 low pathogenic avian influenza viruses in chickens.
              • ZHANG L , Guo ZW, Bridge ES, Li YM, et al
                • Distribution and dynamics of risk factors associated with highly pathogenic avian influenza H5N1.
            • J Immunol
              • WLODARCZYK MF , Kraft AR, Chen HD, Kenney LL, et al
                • Anti-IFN-gamma and Peptide-Tolerization Therapies Inhibit Acute Lung Injury Induced by Cross-Reactive Influenza A-Specific Memory T Cells.
            • J Virol
              • FAN S , Macken CA, Li C, Ozawa M, et al
                • Synergistic effect of the PDZ and the p85beta-binding domains of the NS1 protein in virulence of an avian H5N1 influenza A virus.
              • MARGINE I , Hai R, Albrecht RA, Obermoser G, et al
                • H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.
              • YOON SW , Kayali G, Ali MA, Webster RG, et al
                • A Single Amino Acid at the Hemagglutinin Cleavage Site Contributes to the Pathogenicity but not Transmission of Egyptian Highly Pathogenic H5N1 Influenza Virus in Chickens.
              • AMORIM MJ , Kao R, Digard P
                • Nucleozin targets cytoplasmic trafficking of vRNP-Rab11 complexes in influenza A virus infection.
              • ALFONSO R , Rodriguez A, Rodriguez P, Lutz T, et al
                • CHD6, a cellular repressor of influenza virus replication is degraded in human alveolar epithelial cells and mice lungs during infection.
              • DI PIETRO A , Kajaste-Rudnitski A, Oteiza A, Nicora L, et al
                • TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation.
              • TURNER DL , Bickham KL, Farber DL, Lefrancois L, et al
              • MURCIA PR , Baillie GJ, Stack JC, Jervis C, et al
            • PLoS Comput Biol
              • ALTHOUSE BM , Patterson-Lomba O, Goerg GM, Hebert-Dufresne L, et al
                • The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.
            • PLoS One
              • PEPIN KM , Wang J, Webb CT, Hoeting JA, et al
                • Anticipating the prevalence of avian influenza subtypes h9 and h5 in live-bird markets.
              • FUJIKURA D , Chiba S, Muramatsu D, Kazumata M, et al
                • Type-I Interferon is Critical for FasL Expression on Lung Cells to Determine the Severity of Influenza.
              • ZHU Z , Shi Z, Yan W, Wei J, et al
                • Nonstructural protein 1 of influenza a virus interacts with human guanylate-binding protein 1 to antagonize antiviral activity.
              • XU C , Iuliano AD, Chen M, Cheng PY, et al
                • Characteristics of Hospitalized Cases with Influenza A (H1N1)pdm09 Infection during First Winter Season of Post-Pandemic in China.
              • BUNTHI C , Thamthitiwat S, Baggett HC, Akarasewi P, et al
              • MOORTHY M , Samuel P, Peter JV, Vijayakumar S, et al
                • Estimation of the burden of pandemic(H1N1)2009 in developing countries: experience from a tertiary care center in South India.
              • FEIKIN DR , Njenga MK, Bigogo G, Aura B, et al
                • Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007-2010.
            • Vaccine
              • KOMMAREDDY S , Baudner BC, Bonificio A, Gallorini S, et al
                • Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
              • TOBACK SL , Ambrose CS, Eaton A, Hansen J, et al
                • A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
              • MACINTOSH VH , Tastad KJ, Eick-Cost AA
                • Mid-season influenza vaccine effectiveness 2011-2012: A Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.
              • PASOTO SG , Ribeiro AC, Viana VS, Leon EP, et al
                • Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjogren's syndrome.
              • SHIM E , Galvani AP
              • VAN HELDEN MJ , van Kooten PJ, Bekker CP, Grone A, et al
                • Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.
              • PEETERS M , Regner S, Vaman T, Devaster JM, et al
                • Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials.
            -
            --------

            Comment

            • #7
              Research Articles Abstracts ? February 23 2013 Issue

              [Source: AMEDEO, homepage: (LINK).]

              Research Articles Abstracts ? February 23 2013 Issue




              This week?s abstracts:
              • Antiviral Res
                • GAO X , Wang W, Li Y, Zhang S, et al
                  • Enhanced Influenza VLP Vaccines Comprising Matrix-2 Ectodomain and Nucleoprotein Epitopes Protects mice from Lethal Challenge.
              • J Immunol
                • DEMOOR T , Petersen BC, Morris S, Mukherjee S, et al
                  • IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus.
              • J Infect
                • RAPOSE A
                • CILLONIZ C , Ewig S, Menendez R, Ferrer M, et al
                  • Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia.
              • J Infect Dis
                • PERRONE LA , Belser JA, Wadford DA, Katz JM, et al
                  • Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.
              • JAMA
                • COHEN S , Janicki-Deverts D, Turner RB, Casselbrant ML, et al
                  • Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults.
              • Lancet
              • MMWR Morb Mortal Wkly Rep
                • ?
                  • Update: influenza activity - United States, september 30, 2012-february 9, 2013.
                • ?
                  • Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, february 2013.
              • PLoS One
                • HILLAIRE ML , Nieuwkoop NJ, Boon AC, de Mutsert G, et al
                  • Binding of DC-SIGN to the Hemagglutinin of Influenza A Viruses Supports Virus Replication in DC-SIGN Expressing Cells.
                • HASHEM AM , Gravel C, Farnsworth A, Zou W, et al
                • THOMPSON KA , Pappachan JV, Bennett AM, Mittal H, et al
                  • Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic - The Risk of Aerosol Generation during Medical Procedures.
                • WANG C , Zhang Y, Wu B, Liu S, et al
                  • Evolutionary Characterization of the Pandemic H1N1/2009 Influenza Virus in Humans Based on Non-Structural Genes.
                • PATWARDHAN A , Bilkovski R
                  • Comparison: Flu prescription sales data from a retail pharmacy in the US with Google Flu trends and US ILINet (CDC) data as flu activity indicator.
                • ASATI A , Kachurina O, Kachurin A
                  • Simultaneous measurements of auto-immune and infectious disease specific antibodies using a high throughput multiplexing tool.
              • Vaccine
                • RANDALL LH , Curran EA, Omer SB
                  • Legal considerations surrounding mandatory influenza vaccination for healthcare workers in the United States.
              • Virology
                • ?
                  • Retraction notice to "Direct interaction of cellular hnRNP-F and NS1 of influenza A virus accelerates viral replication by modulation of viral transcriptional activity and host gene expression" [Virology 397 (2010) 89-99].
              -
              -------

              Comment

              • #8
                Research Articles Abstracts?March 4 2013 Issue

                [Source: AMEDEO, homepage: (LINK).]
                Research Articles Abstracts?March 4 2013 Issue



                This week?s abstracts:
                1. TAKEMAE N, Nguyen T, Ngo LT, Hiromoto Y, et al.
                2. MILLER E, Andrews N, Stellitano L, Stowe J, et al.
                3. BARR IG, Jelley LL.
                4. CHAN-TACK KM, Gao A, Himaya AC, Thompson EG, et al.
                5. BARRIA MI, Garrido JL, Stein C, Scher E, et al.
                6. DONIS RO, Cox NJ.
                7. KILLIP MJ, Young DF, Gatherer D, Ross CS, et al.
                8. PENA L, Sutton T, Chockalingam A, Kumar S, et al.
                9. DERMODY TS, Sandri-Goldin RM, Shenk T.
                10. TSE LV, Marcano VC, Huang W, Pocwierz MS, et al.
                11. ZARAKET H, Bridges OA, Russell CJ.
                12. EDWARDS KM, Zhu Y, Griffin MR, Weinberg GA, et al.
                13. KLICK B, Durrani S, Chan KH, Ip DK, et al.
                14. ATO M, Takahashi Y, Fujii H, Hashimoto SI, et al.
                15. YAMAMOTO N, Soda K, Sakoda Y, Okamatsu M, et al.
                -
                -------

                Comment

                • #9
                  Research Articles Abstracts?March 8 2013 Issue

                  [Sourc: AMEDEO, homepage: (LINK).]

                  Research Articles Abstracts?March 8 2013 Issue




                  This week?s abstracts:
                  • Antimicrob Agents Chemother
                    • LEJAL N , Tarus B, Bouguyon E, Chenavas S, et al
                      • Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of Influenza A virus.
                    • ACHENBACH JE , Bowen RA
                      • The effect of oseltamivir carboxylate consumption on the emergence of drug resistant H5N2 avian influenza virus in mallard ducks.
                  • Antiviral Res
                    • GOVORKOVA EA , Baranovich T, Seiler P, Armstrong J, et al
                      • Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.
                  • J Immunol
                    • BRINCKS EL , Roberts AD, Cookenham T, Sell S, et al
                      • Antigen-Specific Memory Regulatory CD4+Foxp3+ T Cells Control Memory Responses to Influenza Virus Infection.
                  • J Infect Dis
                    • KONDURI V , Decker WK, Halpert MM, Gilbert B, et al
                      • Modeling Dendritic Cell Vaccination for Influenza Prophylaxis: Potential Applications for Niche Populations.
                  • J Virol
                    • FONTANA J , Steven AC
                      • At low pH, Influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane.
                    • PETERSEN H , Wang Z, Lenz E, Pleschka S, et al
                      • Reassortment of NS-segments modifies highly-pathogenic avian influenza virus interaction with avian hosts and host cells.
                    • COBBIN JC , Verity EE, Gilbertson BP, Rockman SP, et al
                      • The source of the PB1 gene in influenza vaccine reassortants selectively alters HA content of the resulting seed virus.
                    • JEGASKANDA S , Weinfurter JT, Friedrich TC, Kent SJ, et al
                      • Antibody-dependent cellular cytotoxicity (ADCC) is associated with control of pandemic H1N1 influenza virus infection of macaques.
                    • SANTOS A , Pal S, Chacon J, Meraz K, et al
                      • SUMOylation affects the interferon blocking activity of the influenza A non-structural protein NS1 without affecting its stability or cellular localization.
                  • J Virol Methods
                    • LEONARDI GP , Wilson AM, Zuretti AR
                      • Comparison of Conventional Lateral-Flow Assays and A New Fluorescent Immunoassay to Detect Influenza Viruses.
                  • PLoS One
                    • LEE DH , Park JK, Kwon JH, Yuk SS, et al
                      • Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens.
                    • LEYMARIE O , Jouvion G, Herve PL, Chevalier C, et al
                      • Kinetic Characterization of PB1-F2-Mediated Immunopathology during Highly Pathogenic Avian H5N1 Influenza Virus Infection.
                    • ELY CR , Hall JS, Schmutz JA, Pearce JM, et al
                      • Evidence that Life History Characteristics of Wild Birds Influence Infection and Exposure to Influenza A Viruses.
                    • DE MARCO MA , Porru S, Cordioli P, Cesana BM, et al
                      • Evidence of Cross-Reactive Immunity to 2009 Pandemic Influenza A Virus in Workers Seropositive to Swine H1N1 Influenza Viruses Circulating in Italy.
                    • FIELDING JE , Bergeri I, Higgins N, Kelly HA, et al
                      • The Spread of Influenza A(H1N1)pdm09 in Victorian School Children in 2009: Implications for Revised Pandemic Planning.
                    • DAVEY RT JR , Lynfield R, Dwyer DE, Losso MH, et al
                      • The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies.
                    • DOBROVOLNY HM , Reddy MB, Kamal MA, Rayner CR, et al
                      • Assessing mathematical models of influenza infections using features of the immune response.
                    • NOTI JD , Blachere FM, McMillen CM, Lindsley WG, et al
                    • DUGAS AF , Jalalpour M, Gel Y, Levin S, et al
                    • BLOOM-FESHBACH K , Alonso WJ, Charu V, Tamerius J, et al
                      • Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative Review.
                    • CHEN GW , Tsao KC, Huang CG, Gong YN, et al
                    • SATO Y , Morimoto K, Kubo T, Yanagihara K, et al
                      • High Mannose-Binding Antiviral Lectin PFL from Pseudomonas fluorescens Pf0-1 Promotes Cell Death of Gastric Cancer Cell MKN28 via Interaction with alpha2-Integrin.
                    • MEGREMIS S , Demetriou P, Makrinioti H, Manoussaki AE, et al
                    • BEDKE N , Sammut D, Green B, Kehagia V, et al
                      • Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response.
                    • HOFFMANN J , Rabezanahary H, Randriamarotia M, Ratsimbasoa A, et al
                      • Viral and atypical bacterial etiology of acute respiratory infections in children under 5 years old living in a rural tropical area of Madagascar.
                  • Proc Natl Acad Sci U S A
                    • HARRIS AK , Meyerson JR, Matsuoka Y, Kuybeda O, et al
                      • Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.
                  • Vaccine
                    • SUNDARAM ME , Talbot HK, Zhu Y, Griffin MR, et al
                      • Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old.
                  • Virology
                    • BELSER JA , Szretter KJ, Katz JM, Tumpey TM, et al
                      • Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
                  -
                  -------

                  Comment

                  • #10
                    Research Articles Abstracts?March 15 2013 Issue

                    [Source: AMEDEO, homepage: (LINK).]

                    Research Articles Abstracts?March 15 2013 Issue




                    This week?s abstracts:
                    • Antimicrob Agents Chemother
                      • KITANO M , Kodama M, Itoh Y, Kanazu T, et al
                        • Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
                    • Biochemistry
                      • ANDREAS LB , Barnes AB, Corzilius B, Chou JJ, et al
                        • Dynamic Nuclear Polarization Study of Inhibitor Binding to the M218-60 Proton Transporter from Influenza A.
                    • Cell
                      • MORITA M , Kuba K, Ichikawa A, Nakayama M, et al
                        • The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza.
                    • Epidemiol Infect
                      • CHEN SC , Liao CM
                        • Cost-effectiveness of influenza control measures: a dynamic transmission model-based analysis.
                    • J Gen Virol
                      • SONG MS , Baek YH, Pascua PN, Kwon HI, et al
                        • Establishment of Vero cell RNA polymerase I-driven reverse genetics for influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.
                      • SHELTON H , Roberts KL, Molesti E, Temperton N, et al
                        • Mutations in hemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility.
                    • J Infect
                      • NICOLI EJ , Trotter CL, Turner KM, Colijn C, et al
                        • Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK.
                    • J Infect Dis
                      • DOMACHOWSKE JB , Pankow-Culot H, Bautista M, Feng Y, et al
                        • A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
                      • SANDE CJ , Mutunga MN, Medley GF, Cane PA, et al
                        • Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.
                    • J Virol
                      • SRIVASTAVA V , Yang Z, **** IF, Xu J, et al
                        • Identification of dominant ADCC epitopes on hemagglutinin antigen of pandemic H1N1 influenza virus.
                      • ALAMARES-SAPUAY JG , Martinez-Gil L, Stertz S, Miller MS, et al
                        • Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.
                      • BELSER JA , Davis CT, Balish A, Edwards LE, et al
                        • Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.
                    • J Virol Methods
                      • SAKTHIVEL SK , Whitaker B, Lu X, Oliveira DB, et al
                        • Comparison of fast-track diagnostics respiratory pathogens multiplex real-time RT-PCR assay with in-house singleplex assays for comprehensive detection of human respiratory viruses.
                    • PLoS Med
                      • CAUCHEMEZ S , Epperson S, Biggerstaff M, Swerdlow D, et al
                        • Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus.
                    • PLoS One
                      • LIU X , He Y, Xiao K, White JR, et al
                        • Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection.
                      • STARK GV , Long JP, Ortiz DI, Gainey M, et al
                      • WILSON HM , Hall JS, Flint PL, Franson JC, et al
                        • High Seroprevalence of Antibodies to Avian Influenza Viruses among Wild Waterfowl in Alaska: Implications for Surveillance.
                      • LO YC , Chuang JH, Kuo HW, Huang WT, et al
                        • Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza b/yamagata-lineage viruses in taiwan, 2011-12 season.
                      • BARBOZA P , Vaillant L, Mawudeku A, Nelson NP, et al
                        • Evaluation of Epidemic Intelligence Systems Integrated in the Early Alerting and Reporting Project for the Detection of A/H5N1 Influenza Events.
                    -
                    -------

                    Comment

                    • #11
                      Research Articles Abstracts?March 23 2013 Issue

                      [Source: AMEDEO, homepage: (LINK).]

                      Research Articles Abstracts?March 23 2013 Issue




                      This week?s abstracts:
                      • Arch Virol
                        • STEFANSKA I , Dzieciatkowski T, Brydak LB, Romanowska M, et al
                          • Application of three duplex real-time PCR assays for simultaneous detection of human seasonal and avian influenza viruses.
                      • Drug Saf
                        • CHAVANT F , Ingrand I, Jonville-Bera AP, Plazanet C, et al
                          • The PREGVAXGRIP Study: a Cohort Study to Assess Foetal and Neonatal Consequences of In Utero Exposure to Vaccination Against A(H1N1)v2009 Influenza.
                      • Epidemiol Infect
                        • ZENG XJ , Lin Y, Zhao YB, Lu CP, et al
                      • J Immunol
                        • DUTTA A , Miaw SC, Yu JS, Chen TC, et al
                          • Altered T-bet Dominance in IFN-gamma-Decoupled CD4+ T Cells with Attenuated Cytokine Storm and Preserved Memory in Influenza.
                      • J Virol
                        • ZHANG W , Shi Y, Qi J, Gao F, et al
                          • Molecular basis of the receptor binding specificity switch of the hemagglutinins from the 1918 and 2009 pandemic influenza A viruses by D225G substitution.
                        • LI Z , Gabbard JD, Mooney A, Gao X, et al
                          • Single Dose Vaccination Of A Recombinant Parainfluenza Virus 5 Expressing NP From H5N1 Provides Broad Immunity Against Influenza A Viruses.
                        • LUONGO C , Winter CC, Collins PL, Buchholz UJ, et al
                          • Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature sensitive live-attenuated vaccine candidate that is phenotypically stable at physiological temperature.
                        • URAKI R , Kiso M, Shinya K, Goto H, et al
                      • J Virol Methods
                        • TERLETSKAIA-LADWIG E , Meier S, Enders M
                          • Improved high-throughput virus neutralisation assay for antibody estimation against pandemic and seasonal influenza strains from 2009-2011.
                        • ARVIA R , Corcioli F, Azzi A
                          • High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses.
                      • Lancet
                        • SALMON DA , Proschan M, Forshee R, Gargiullo P, et al
                          • Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
                      • PLoS Comput Biol
                        • LARSSON P , Kasson PM
                          • Lipid tail protrusion in simulations predicts fusogenic activity of influenza fusion Peptide mutants and conformational models.
                        • WELLS CR , Klein EY, Bauch CT
                          • Policy resistance undermines superspreader vaccination strategies for influenza.
                      • PLoS One
                        • LEWIS NS , Javakhishvili Z, Russell CA, Machablishvili A, et al
                        • WANG IK , Lin CL, Lin PC, Liang CC, et al
                          • Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study.
                        • KATZOV-ECKERT H , Botosso VF, Neto EA, Zanotto PM, et al
                          • Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children.
                        • TRICCO AC , Lillie E, Soobiah C, Perrier L, et al
                        • SANTINI-OLIVEIRA M , Camacho LA, Souza TM, Luz PM, et al
                          • H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses.
                      • Vaccine
                        • YOO BK , Humiston SG, Szilagyi PG, Schaffer SJ, et al
                          • Cost effectiveness analysis of elementary school-located vaccination against influenza-Results from a randomized controlled trial.
                        • GORSE GJ , Falsey AR, Fling JA, Poling TL, et al
                          • Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
                        • JACKSON ML , Nelson JC
                          • The test-negative design for estimating influenza vaccine effectiveness.
                        • BRAGSTAD K , Vinner L, Hansen MS, Nielsen J, et al
                          • A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
                      • Virus Res
                        • SMITH AM , McCullers JA
                          • Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.
                      -
                      ------

                      Comment

                      • #12
                        Research Articles Abstracts ? March 29 2013 Issue

                        [Source: AMEDEO, homepage: (LINK).]

                        Research Articles Abstracts ? March 29 2013 Issue




                        This week?s abstracts:
                        • Antiviral Res
                          • SAMSON M , Pizzorno A, Abed Y, Boivin G, et al
                          • LEE YN , Youn HN, Kwon JH, Lee DH, et al
                            • Sublingual administration of Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against influenza virus infection in mice.
                          • HAASBACH E , Hartmayer C, Planz O
                            • Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
                        • Epidemiol Infect
                          • BIGGERSTAFF M , Jhung MA, Reed C, Garg S, et al
                            • Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010.
                        • J Immunol
                          • GRAHAM AC , Hilmer KM, Zickovich JM, Obar JJ, et al
                            • Inflammatory Response of Mast Cells during Influenza A Virus Infection Is Mediated by Active Infection and RIG-I Signaling.
                        • J Virol
                          • MARTINEZ-ROMERO C , de Vries E, Belicha-Villanueva A, Mena I, et al
                            • Substitutions T200A and E227A in the hemagglutinin of pandemic 2009 influenza A virus increase lethality but decrease transmission.
                          • WANG S , Zhao Z, Bi Y, Sun L, et al
                            • Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling its nuclear import.
                        • J Virol Methods
                          • WANG R , Zhao J, Jiang T, Kwon YM, et al
                            • Selection and characterization of DNA aptamers for use in detection of avian influenza virus H5N1.
                        • PLoS One
                          • VITELLI A , Quirion MR, Lo CY, Misplon JA, et al
                            • Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo
                          • MATHEU MP , Teijaro JR, Walsh KB, Greenberg ML, et al
                            • Three Phases of CD8 T Cell Response in the Lung Following H1N1 Influenza Infection and Sphingosine 1 Phosphate Agonist Therapy.
                          • SCHRAUWEN EJ , Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, et al
                            • Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments.
                          • BOONYARATANAKORNKIT J , Schomacker H, Collins P, Schmidt A, et al
                            • Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System.
                          • IBANEZ LI , Roose K, De Filette M, Schotsaert M, et al
                            • M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A.
                          • LIU X , Liu Y, Zhang Y, Chen Z, et al
                            • Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population.
                          • ZOU J , Yang H, Cui H, Shu Y, et al
                            • Geographic Divisions and Modeling of Virological Data on Seasonal Influenza in the Chinese Mainland during the 2006-2009 Monitoring Years.
                          • FENICHEL EP , Kuminoff NV, Chowell G
                          • WEAVER JM , Yang H, Roumanes D, Lee FE, et al
                            • Increase in IFNgamma(-)IL-2(+) Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza.
                        • Virus Res
                          • SPACKMAN E , Swayne DE
                            • Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: Current questions and new technology.
                        -
                        --------

                        Comment

                        • #13
                          Research Articles Abstracts?April 4 2013 Issue

                          [Source: AMEDEO, homepage: (LINK).]

                          Research Articles Abstracts?April 4 2013 Issue




                          This week?s abstracts:
                          • BMJ
                          • Eur J Epidemiol
                            • GALEOTTI F , Massari M, D'Alessandro R, Beghi E, et al
                          • PLoS One
                            • GREENWAY KT , Legresley EB, Pinto BM
                              • The influence of 150-cavity binders on the dynamics of influenza a neuraminidases as revealed by molecular dynamics simulations and combined clustering.
                            • JOB ER , Bottazzi B, Gilbertson B, Edenborough KM, et al
                            • XU Z , Shen F, Li X, Wu Y, et al
                              • Molecular and microscopic analysis of bacteria and viruses in exhaled breath collected using a simple impaction and condensing method.
                            • SIEGRIST CA , van Delden C, Bel M, Combescure C, et al
                              • Higher Memory Responses in HIV-Infected and Kidney Transplanted Patients than in Healthy Subjects following Priming with the Pandemic Vaccine.
                            • EMPEY KM , Orend JG, Peebles RS Jr, Egana L, et al
                              • Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.
                          • Virology
                            • CHAKRABARTI AK , Pasricha G
                              • An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses.
                            • ASHRAF S , Brockman-Schneider R, Bochkov YA, Pasic TR, et al
                              • Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells.
                          -
                          ------

                          Comment

                          • #14
                            Research Articles Abstracts?April 13 2013 Issue

                            [Source: AMEDEO, homepage: (LINK).]

                            Research Articles Abstracts?April 13 2013 Issue



                            This week?s abstracts:
                            1. EDWARDS AS.
                            2. FINNIE TJ, Copley VR, Hall IM, Leach S, et al.
                            3. GOUYON JB, Roze JC, Guillermet-Fromentin C, Glorieux I, et al.
                            4. BINNICKER MJ, Baddour LM, Grys TE, Espy MJ, et al.
                            5. AHMED S, Maratha A, Butt AQ, Shevlin E, et al.
                            6. KALLFASS C, Lienenklaus S, Weiss S, Staeheli P, et al.
                            7. BAZ M, Paskel M, Matsuoka Y, Zengel J, et al.
                            8. KRAMMER F, Pica N, Hai R, Margine I, et al.
                            9. TAFESSE FG, Sanyal S, Ashour J, Guimaraes CP, et al.
                            10. TSAI CS, Yen HY, Lin MI, Tsai TI, et al.
                            11. CHU FL, Wen HL, Hou GH, Lin B, et al.
                            -
                            -------

                            Comment

                            • #15
                              Research Articles Abstracts?April 20 2013 Issue

                              [Source: AMEDEO, homepage: (LINK).]

                              Research Articles Abstracts?April 20 2013 Issue



                              This week?s abstracts:
                              • Antiviral Res
                                • KIM EH , Pascua PN, Song MS, Baek YH, et al
                                  • Immunomodulaton and attenuation of lethal Influenza A virus infection by oral administration with KIOM-C.
                                • LAURSEN NS , Wilson IA
                                  • Broadly neutralizing antibodies against influenza viruses.
                                • HUI DS , Lee N, Chan PK
                                  • Adjunctive therapies and immunomodulatory agents in the management of severe influenza.
                              • Arch Virol
                                • ZHANG Y , Wang N, Cao J, Chen H, et al
                                  • Genetic characterization of H1N2 swine influenza virus isolated in China and its pathogenesis and inflammatory responses in mice.
                              • BMJ
                              • Drug Saf
                                • JONES M , Hama R, Jefferson T, Doshi P, et al
                              • Epidemiol Infect
                                • THOMAS HL , Andrews N, Green HK, Boddington NL, et al
                                  • Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems.
                              • J Gen Virol
                                • FOX JM , Sage LK, Huang L, Barber J, et al
                                  • Inhibition of indoleamine 2, 3- dioxygenase (IDO) enhances the T cell response to influenza virus infection.
                                • SAGE LK , Fox JM, Tompkins SM, Tripp RA, et al
                                  • Subsisting H1N1 Influenza Memory Responses are Insufficient to Protect from Pandemic H1N1 Influenza Challenge in C57BL/6 Mice.
                              • J Infect Dis
                                • MARTIN ET , Fairchok MP, Stednick ZJ, Kuypers J, et al
                                • MELLA C , Suarez-Arrabal MC, Lopez S, Stephens J, et al
                                  • Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.
                              • J Virol
                                • AMMAYAPPAN A , Nace R, Peng KW, Russell SJ, et al
                                  • Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites.
                              • N Engl J Med
                                • UYEKI TM , Cox NJ
                                • GAO R , Cao B, Hu Y, Feng Z, et al
                              • PLoS Comput Biol
                                • PARTON DL , Tek A, Baaden M, Sansom MS, et al
                                  • Formation of Raft-Like Assemblies within Clusters of Influenza Hemagglutinin Observed by MD Simulations.
                              • PLoS One
                                • STONE R , Takimoto T
                                  • Critical Role of the Fusion Protein Cytoplasmic Tail Sequence in Parainfluenza Virus Assembly.
                                • TAKAHASHI T , Takaguchi M, Kawakami T, Suzuki T, et al
                                  • Sulfatide Regulates Caspase-3-Independent Apoptosis of Influenza A Virus through Viral PB1-F2 Protein.
                                • HAN N , Mu Y
                                  • Plasticity of 150-Loop in Influenza Neuraminidase Explored by Hamiltonian Replica Exchange Molecular Dynamics Simulations.
                                • LINDSKOG C , Ellstrom P, Olsen B, Ponten F, et al
                                • MURAKI Y , Okuwa T, Himeda T, Hongo S, et al
                                  • Effect of Cysteine Mutations in the Extracellular Domain of CM2 on the Influenza C Virus Replication.
                                • MILNE GJ , Halder N, Kelso JK
                                  • The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
                                • ECHENIQUE IA , Chan PA, Chapin KC, Andrea SB, et al
                                  • Clinical Characteristics and Outcomes in Hospitalized Patients with Respiratory Viral Co-Infection during the 2009 H1N1 Influenza Pandemic.
                                • MATA M , Sarrion I, Armengot M, Carda C, et al
                                  • Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine.
                              -
                              -------

                              Comment

                              Previous 1 4 template Next
                              Working...
                              X